Moran et al (122) have demonstrated that osteoprotegerin (OPG) is positively associated with AAA in human (122) and knockout of OPG limited AAA progression and reduced aortic MMP-2 and -9 expression in AngII-infused ApoE−/− mouse (34). This evidence concerns the gene MMP2 and triple-A syndrome.